Huiqi Liu

Xining, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Tissue factor drives pancreatic ductal adenocarcinoma invasion and metastasis and is therapeutically targeted by hydroxygenkwanin.

Tissue factor drives pancreatic ductal adenocarcinoma invasion and metastasis and is therapeutically targeted by hydroxygenkwanin.

Journal: Cellular signalling
Published: May 14, 2026

High glycolysis phenotype influences malignant progression and poor prognosis of gastric cancer through the PI3K/AKT pathway.

High glycolysis phenotype influences malignant progression and poor prognosis of gastric cancer through the PI3K/AKT pathway.

Journal: Neoplasma
Published: March 21, 2025

Hsa-let-7d-5p Promotes Gastric Cancer Progression by Targeting PRDM5.

Hsa-let-7d-5p Promotes Gastric Cancer Progression by Targeting PRDM5.

Journal: Journal of oncology
Published: March 11, 2022

miRNA-381-3p Functions as a Tumor Suppressor to Inhibit Gastric Cancer by Targeting Fibroblast Growth Factor Receptor-2.

miRNA-381-3p Functions as a Tumor Suppressor to Inhibit Gastric Cancer by Targeting Fibroblast Growth Factor Receptor-2.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: January 14, 2022

Analysis of microRNA expression in CD133 positive cancer stem‑like cells of human osteosarcoma cell line MG-63.

Analysis of microRNA expression in CD133 positive cancer stem‑like cells of human osteosarcoma cell line MG-63.

Journal: PeerJ
Published: April 29, 2021

[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.

[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.

Journal: Oncology reports
Published: December 13, 2019

Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.

Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.

Journal: Oncology reports
Published: December 13, 2019

[Retracted] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.

[Retracted] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.

Journal: Oncology reports
Published: December 13, 2019
Showing 1-8 of 8

Last Updated: 09/26/2026